Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer
Clinical trial NCT05922930 · SUSPENDED
Trial details
- NCT number
- NCT05922930
- Sponsor
- M.D. Anderson Cancer Center
- Status
- SUSPENDED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-11
- Primary completion
- 2027-10-15
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.